Difference between revisions 538147515 and 538147762 on enwiki

'''Zerona''' is a low-level laser device developed by Erchonia Corp. for non-invasive body slimming of the waist, hips, and thighs. It has been shown to disrupt [[adipocyte]], or fat cell, membranes causing the release of stored [[lipids]] and fatty material, in turn, promoting adipocyte collapse. The device was first introduced to the market in 2008 as an [[off-label use]] device for slimming, but later was granted 510k market clearance by the [[Food and Drug Administration]] (contracted; show full)st4=David I. |last4=Turok |first5=Ryan J. |last5=Maloney |year=2009 |url=http://www.erchonia.com/files/uploads/1/file/Jackson_3LT%20Non-Invasive%20Approach%20for%20Body%20Contouring%20Randomized%20Controlled%20Study_LISM_12_09.pdf |title=Low-Level Laser Therapy as a Non-Invasive Approach for Body Contouring: A Randomized, Controlled Study |journal=Lasers in Surgery and Medicine |volume=41 |issue=10 |pages=799–809 |doi=10.1002/lsm.20855}}</ref>

== Device ==
Zerona is a class II low-level laser under 
[[21 CFR]] 878.540. [[Low level laser therapy]] (LLLT) represents a division of [[photomedicine]] utilizing defined parameters of laser light for the treatment of a specific medical ailment.  The efficacy and safety of this subtle therapeutic approach is dependent on the [[wavelength]], [[dosage]], pulsation, and [[intensity]] being applied. For instance, laser therapy has exhibited a biphasic dose response revealing that too much applied energy could hamper or prevent the desired clinical outcome from transpiring.&l(contracted; show full)==External links==
*[http://www.erchonia.com/ Erchonia Corp., Official Website]

== References ==
{{reflist}}

[[Category:Laser medicine]]
[[Category:Management of obesity]]